Body Weight Reduction in Women Treated with Tirzepatide by Reproductive Stage: A Post Hoc Analysis from the SURMOUNT Program. Obesity , 12 Mar
Key Takeaways Before the FDAs decision, the need for compounded semaglutide was extremely high
New England Journal of Medicine, 387(3), pp.205216
Weight loss and thyroid hormone requirements : Substantial weight loss achieved through GLP-1 therapy may alter thyroid hormone requirements
Patients should seek urgent medical attention if they experience: Severe or persistent abdominal pain (possible pancreatitis or gallbladder complication) Signs of dehydration (dizziness, reduced urine output) due to vomiting or diarrhoea Symptoms of hypoglycaemia (shakiness, sweating, confusion) or hyperglycaemia (excessive thirst, frequent urination) Severe headache or visual disturbance (possible raised intracranial pressure) Signs of an allergic reaction (rash, swelling, difficulty breathing) Regular monitoring should include fasting glucose, HbA1c, IGF-1, lipid panels, liver function, and renal function